No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
STEMCELL Launches Novel Cell-Engineering CellPore Transfection System
Genenta Welcomes New Directors John L. Cantello, Lauren H. Chung, Armon R. Sharei, and Todd Wider
STEMCELL Technologies Announces Successful Asset Purchase Agreement With SQZ Biotechnologies Company
Asset Sale and Plan of Liquidation and Dissolution Approved by SQZB Shareholders
SQZ Biotechnologies GAAP EPS of -$0.80 Misses by $0.30, Revenue of $0M
SQZ Biotechnologies Reports Third Quarter 2023 Financial Results and Recent Portfolio Updates
No Data